Provocation After Nurse-Directed Assessment (PANDA) Study

Not yet recruitingOBSERVATIONAL
Enrollment

440

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2029

Conditions
Drug AllergyPenicillin Allergy
Interventions
DIAGNOSTIC_TEST

Nurse-led penicillin allergy delabelling service

Patients in this group undergo risk assessment and categorization by nurses to identify low-risk individuals for delabeling. For these patients, nurses will collaborate with allergists in the delabeling process.

DIAGNOSTIC_TEST

Allergist-led penicillin allergy delabelling service

Patients assigned to this group will undergo risk assessment and delabeling led by allergists for both low-risk and high-risk cases.

Trial Locations (4)

999077

Prince of Wales Hospital, Hong Kong

Princess Margaret Hospital, Hong Kong

Queen Elizabeth Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT07127835 - Provocation After Nurse-Directed Assessment (PANDA) Study | Biotech Hunter | Biotech Hunter